The short answer first: whether your stock token carries voting rights and a dividend does not depend on the company name shown in the trading interface, but on how the token is built in lega
The short answer first: whether your stock token carries voting rights and a dividend does not depend on the company name shown in the trading interface, but on how the token is built in legal terms. Since September 17, 2026 there is an official yardstick for this for the first time. The US Securities and Exchange Commission has granted a time-limited exemption allowing trading venues to handle tokenized US stocks, and it has tied that permission to one condition: the token must embody the same rights as the real share. The condition binds venues under US supervision. It does not automatically cover the token you buy in Germany through a provider based outside the United States. That gap is exactly where you have to look for yourself.
A stock token is a tradable entry on a public blockchain intended to mirror the economic value of a real share. Tokens like these are not on the shelf at your high-street bank. You find them at crypto exchanges and crypto brokers, you usually pay for them with a stablecoin, and you keep them in the same wallet as the rest of your crypto holdings. That makes this your business as a crypto investor: custody, fees, your tax return and, in the worst case, insolvency protection all run through the crypto side of your portfolio, not the securities side.
The SEC has granted what it calls an innovation exemption, a time-limited and conditional exemption from the definition of an "exchange" under the US Securities Exchange Act of 1934. The beneficiaries are trading venues the regulator refers to as tokenized securities venues, or TSVs. A TSV brings together buyers and sellers of tokenized US stocks without having to be registered as an exchange, and it may use approved liquidity pools and automated market makers to do so. An automated market maker is a trading mechanism in which a liquidity pool sets prices according to a fixed formula, rather than matching buy and sell orders against each other in an order book.
The exemption runs for five years, and the SEC has explicitly invited comment on possible changes. The details are set out in the SEC announcement of September 17, 2026; a reading of the conditions, including a quote from an SEC spokesperson, is available at Unchained.
One point matters for understanding the whole construction: an exemption from the definition of an exchange is not a licence to operate as one. The venue is permitted to work without an exchange licence for as long as it meets the conditions. If a condition falls away, the permission falls away with it. That is what separates this exemption from a permanent market authorization, and it is why the conditions matter more to you as an investor than the permission itself.
The condition that matters most to investors is equality of rights. A token may only trade on such a venue if it embodies the same rights as the underlying share. That includes the dividend, the voting right and access to proxy voting. The trade publication Ledger Insights points out that the exemption even permits an unrelated third party to tokenize a company's shares, but only with the full set of rights attached.
This is notable, because until now the rights question around tokenized stocks has usually been answered with a no. In many of the structures available on the market you hold a claim against an issuer who in turn keeps the share in custody somewhere. What you actually own in that case is something we took apart in our analysis of tokenized stocks and issuer risk.
This is the point the German-language coverage of the decision has so far left out. The exemption covers NMS stocks on venues under US supervision. NMS stocks are those regularly listed on US exchanges and covered by the National Market System. The equal-rights condition therefore binds the US venue. A provider based outside the United States is not caught by it, and that is precisely where many German investors buy their stock tokens today.
In practice that means nothing follows for your own portfolio from the headline that the regulator now demands full shareholder rights. It may well be that your token still carries no voting rights and that this is entirely compliant, because your provider never fell under the exemption in the first place. What does emerge is a new benchmark against which you can measure your provider's terms. How to recognize a provider and the structure behind it is something we set out step by step in our guide to identifying stock token issuers.
Two casings that look the same from the outside: only a look inside shows whether a stock token actually holds any rights.
With the same decision, the SEC drew a dividing line. Synthetic stock tokens do not fall under the exemption. A synthetic stock token is not backed by real shares; it replicates the price through a derivative or through an agreement with the provider. According to Unchained, an SEC spokesperson said such products could stay "out in the wilds". That statement describes the regulator's view of the scope of the rules, not an assessment of the products themselves.
For you this is the most useful dividing line in the entire decision, because you can trace it at your own provider. If a real, custodied share sits behind the token, there is a custodian, a backing ratio and, as a rule, evidence of it. If a derivative sits behind it, the terms will name a counterparty whose solvency you are buying along with the product. If you want to work through the difference between a replicated price and a backed holding in practice, our crypto broker comparison sets the models side by side, including the question of who becomes your counterparty.
The third condition is the one that settles the longest-running dispute. If a venue wants to tokenize the shares of a company it does not control, it must notify that company in writing beforehand and wait 30 days. If the company objects within that window, the token may not be traded on that venue. If it stays silent, that counts as consent.
Whether companies should be given such a right of objection was an open question before the decision, and the industry answered it in opposite ways. Trading venues argued that a share is freely tradable once bought and that the issuer does not get to dictate where it trades. Companies and registrars countered that a token carrying a promise of voting rights reaches into their shareholder structure. The regulator came down in favour of a right to object with a deadline.
For you this has an awkward side effect worth planning for: a stock token can disappear from a venue because the company objected, not because anything is wrong with the token. What happens to an open position in that case is not covered by the SEC decision. It is covered by your provider's terms. Check there whether a redemption at net asset value is provided for, or a forced liquidation at whatever the market price happens to be.
The sequence below works regardless of where your provider is based. You do not need legal advice for it, only patience with the documents.
Search the issuance terms or the key information document for the words voting right, dividend and general meeting. If you cannot find them, that is already your answer. The product page showing the share price is the wrong place to look, because it describes the price history and not the legal position.
Establish who holds the real share and in what ratio it stands to the token. What matters is whether there is a named custodian, whether one-to-one backing is promised and whether evidence of it is published.
The hardest test is the past. If the company paid a dividend or carried out a split in the past year, look through your transaction history to see whether and how it reached you. A token that has never passed on a dividend carries no dividend right, whatever the description says.
This is where the exercise becomes practical, because in Germany this precise question determines your tax bill. The classification turns on the legal structure of the token. If it certifies a claim to repayment in cash against an issuer, the gain counts as investment income under section 20 of the German Income Tax Act. The flat withholding tax of 25 percent then applies, plus the solidarity surcharge and, where applicable, church tax, and it applies regardless of how long you have held. If there is no such claim, classification as another economic asset comes into play, and with it the one-year holding period for private disposals under section 23 of the Income Tax Act.
The difference is substantial. In the first case you pay on every gain, even after five years. In the second, a gain is tax-free after a holding period of one year, while a shorter holding period is taxed at your personal rate. Which of the two applies to your token is not something you can read off the price display, but you can read it off the issuance terms. Classification in an individual case is a job for a tax adviser; the groundwork you can do yourself.
Deadlines carry this decision: 30 days for the objection, five years for the exemption itself.
The exemption expires after five years. Until the order is printed in the Federal Register, the official gazette, the end date is not fixed to a particular day, because the deadline runs from that publication. What counts for you is the order of magnitude: the framework such a venue operates under is set for a limited time and will be revised within it, since the regulator is collecting comments.
Anyone who wants to treat tokenized stocks as a long-term building block in their portfolio should factor that in. A ten-year holding period meets a legal framework whose current version ends after five. That is not a reason to stay away, but it is a reason to know the exit route in advance and to read the terms repeatedly rather than only once at the point of purchase.
The SEC has no authority over the German legal framework, but the question of which rights are embodied arises here just the same, only against a different yardstick. Germany's financial regulator BaFin classifies tokenized investments as securities where they are tradable in a way that resembles an exchange in practice. The concept of a security comes from Directive 2014/65/EU, known as MiFID II, and it requires three features at once: transferability, tradability on financial markets, and the embodiment of securities-like rights in the token.
That last feature is the rights question again. A token embodying shareholder rights therefore moves into the territory of securities law, and with it into the remit of the securities regulator, bringing prospectus and authorization duties for the provider. The European crypto regulation MiCA expressly does not apply here, because it carves out financial instruments; those are governed by MiFID II. With the Future Financing Act, Germany has additionally created the option of issuing shares electronically as central register shares and as crypto shares. How such a register works, and why the registrar is the decisive point, is settled at the level of register administration and the transfer agent, meaning the body that maintains the shareholder register.
Both legal orders produce the same test pattern for you. The more genuine shareholder rights a token carries, the more it is treated like a security, with the duties and the level of protection that come with that. The fewer it carries, the more it remains a crypto product with a counterparty in the background.
Supporters of these products argue that they open up trading beyond exchange hours, that fractions of expensive shares become accessible and that settlement runs faster than through the classic securities chain. The US regulator itself gives as the purpose of its exemption the wish to enable innovation while gathering experience.
Against a large portfolio allocation stand the points this article works through: issuer and custody risk, the open rights position outside US venues, the unclear tax classification in individual cases and the time limit on the framework. This weighing up is no substitute for advice and is deliberately not a recommendation for any single provider. The list shows which questions you want answered before money goes into a product of this kind.
(As of September 17, 2026. This article is not investment advice. Prices and fee structures change; check the terms with the provider before you buy.)
